Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| CRITICAL THERAPEUTICS INC | 89,785 | reported | 30 Aug 2013 | tx 10+231,375−43,590 |
| Aclaris Therapeutics, Inc. | 33,523 | reported | 01 Jun 2024 | tx 28+164,714−38,941 |
| LIFECORE BIOMEDICAL, INC. \DE\ | 27,477 | reported | 04 Jun 2022 | tx 17+62,953−26,477 |
| ARS Pharmaceuticals, Inc. | 18,000 | reported | 10 Jun 2022 | tx 3+54,009 |
| COLLAGENEX PHARMACEUTICALS INC | 3,850 | reported | 28 Nov 2007 | tx 8+121,250 |
| INTERMUNE INC | 0 | reported | 29 Sept 2014 | tx 22+236,527−215,081 |
| Synthorx, Inc. | 0 | reported | 23 Jan 2020 | tx 4+33,404−33,404 |
| IMCLONE SYSTEMS INC/DE | 0 | reported | 24 Nov 2008 | tx 5+60,000−60,000 |
| MEDIVATION, INC. | 0 | reported | 28 Sept 2016 | tx 11+87,775−124,959 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 01 Jun 2024 | EXERCISE | Aclaris Therapeutics, Inc. | 4,660 | — | |
| 01 Jun 2024 | EXERCISE | Aclaris Therapeutics, Inc. | 4,660 | 0.00 USD | deriv |
| 04 Mar 2024 | PURCHASE | Aclaris Therapeutics, Inc. | 6,000 | 1.25 USD | |
| 01 Mar 2024 | PURCHASE | Aclaris Therapeutics, Inc. | 8,500 | 1.23 USD | first after silence |
| 02 Jun 2023 | EXERCISE | Aclaris Therapeutics, Inc. | 4,507 | — | |
| 01 Jun 2023 | GRANT_AWARD | Aclaris Therapeutics, Inc. | 4,660 | 0.00 USD | deriv |
| 01 Jun 2023 | GRANT_AWARD | Aclaris Therapeutics, Inc. | 15,750 | 0.00 USD | deriv |
| 02 Jun 2023 | EXERCISE | Aclaris Therapeutics, Inc. | 4,507 | 0.00 USD | deriv |
| 08 Nov 2022 | GIFT | Aclaris Therapeutics, Inc. | 4,000 | 0.00 USD | |
| 10 Jun 2022 | GRANT_AWARD | ARS Pharmaceuticals, Inc. | 18,000 | 0.00 USD | deriv |
| 04 Jun 2022 | GRANT_AWARD | LIFECORE BIOMEDICAL, INC. \DE\ | 7,059 | 9.50 USD | |
| 04 Jun 2022 | EXERCISE | LIFECORE BIOMEDICAL, INC. \DE\ | 7,059 | 9.50 USD | deriv |
| 03 Jun 2022 | EXERCISE | Aclaris Therapeutics, Inc. | 3,356 | — | |
| 16 May 2022 | GIFT | Aclaris Therapeutics, Inc. | 709 | 0.00 USD | |
| 02 Jun 2022 | GRANT_AWARD | Aclaris Therapeutics, Inc. | 15,750 | 0.00 USD | deriv |
| 02 Jun 2022 | GRANT_AWARD | Aclaris Therapeutics, Inc. | 4,507 | 0.00 USD | deriv |
| 03 Jun 2022 | EXERCISE | Aclaris Therapeutics, Inc. | 3,356 | 0.00 USD | deriv |
| 31 May 2022 | GRANT_AWARD | LIFECORE BIOMEDICAL, INC. \DE\ | 9,474 | — | deriv |
| 23 Nov 2021 | GIFT | Aclaris Therapeutics, Inc. | 5,500 | 0.00 USD | |
| 04 Jun 2021 | GRANT_AWARD | ARS Pharmaceuticals, Inc. | 15,000 | 0.00 USD | deriv |
| 04 Jun 2021 | GRANT_AWARD | LIFECORE BIOMEDICAL, INC. \DE\ | 7,059 | — | deriv |
| 03 Jun 2021 | GRANT_AWARD | Aclaris Therapeutics, Inc. | 3,356 | 0.00 USD | deriv |
| 03 Jun 2021 | GRANT_AWARD | Aclaris Therapeutics, Inc. | 12,250 | 0.00 USD | deriv |
| 01 Jun 2021 | GRANT_AWARD | LIFECORE BIOMEDICAL, INC. \DE\ | 8,303 | 11.64 USD | |
| 01 Jun 2021 | EXERCISE | LIFECORE BIOMEDICAL, INC. \DE\ | 8,303 | 11.64 USD | deriv |
2 purchases reported after at least 12 months of silence — most recent on 01 Mar 2024.